A Study of MG4101 (Allogeneic Natural Killer Cell) for Intermediate-stage of Hepatocellular Carcinoma
Clinical trial NCT02854839 · COMPLETED
Trial details
- NCT number
- NCT02854839
- Sponsor
- GC Cell Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-28
- Primary completion
- 2018-09-27
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.